Lung Cancer Surgery Market

Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021

Report Code: MD 4960 Jan, 2017, by marketsandmarkets.com

[135 Pages Report] The lung cancer surgery market is projected to reach USD 29.99 billion by 2021 from USD 21.58 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. Increasing prevalence of lung cancer, rising ageing population, rising awareness about advanced treatment methods are the major driving factors for this market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

Drivers

  • Technological advancements in the lung cancer treatment
  • Increasing incidence and prevalence of lung cancer
  • Rising geriatric population

Restraint

  • High cost of lung cancer surgery

Opportunities

  • Untapped emerging markets

Challenges

  • Entry barriers for new players

The objectives of this study are as follows:

  • To define, describe, and forecast the global lung cancer surgery market by device, surgery, and region
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  •  To track and analyze competitive developments such as product launches, agreements, expansions, acquisitions, and other developments in the global lung cancer surgery market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the global lung cancer surgery market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation—by devices, surgeries, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources referred to for this research study include publications from government sources such as the white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations have been used to identify and collect information useful for this extensive commercial study of the lung cancer surgery market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the lung cancer surgery market. The breakdown of profiles of primaries is shown in the figure below:

Lung Cancer Surgery Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the lung cancer surgery market are Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).

Target Audience for this Report:

  • Manufacturers of Surgical Robots and Lasers
  • Vendors and Distributors of Powered Surgical Instruments
  • Hospitals
  • Research Institutes Related to Cancer Studies
  • Venture Capitalists and Investors

Value Addition for the Buyer:

This report provides insights into the global lung cancer surgery market. It provides valuable information on the devices, procedures, and regions in the lung cancer surgery market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their device offerings and understand strategies undertaken by them to be competitive in this market.

The above-mentioned information would help the buyer understand market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.

Major Market Developments

  • In 2016, Accuray Incorporated signed a long-term agreement with medPhoton (Austria) for Volumetric Image Guidance Solutions for the CyberKnife System.
  • In 2016, Intuitive Surgical announced the USFDA clearance for da Vinci Xi single site instrument and accessories. This technology allows surgeons to operate through a single incision.

Critical questions the report answers

  • How the market developments of key players impact the overall industry?
  • What are the restraining factors for this market?

According to data from the Lung Cancer Journal, in 2005, the economic burden of lung cancer was estimated to be ~USD 46,000 for total treatment per patient. Currently, various types of surgeries for the treatment of lung cancer are available in the market. However, the high cost of surgeries is one of the major factors limiting their adoption, especially among middle-income and low-income population. According to an article published by NCBI, the cost of lung cancer radiation therapy was ~USD 10,000— USD 50,000 in 2012. According to the Healthcare Cost and Utilization Project (HCUP), as of 2009, the hospitalization cost for lung cancer treatment was around USD 2,200 per day. Considering these high costs, in spite of the presence of a large patient pool, a limited number of patients opt for surgical interventions for the treatment of their condition. This is a major factor restraining market growth.

Scope of the Report:

This report categorizes the lung cancer surgery market into the following segments:

Lung Cancer Surgical Devices Market, by Type

  • Surgical Instruments
  • Hand Instruments
    • Stapler
    • Forceps
    • Retractors
    • Rib Shear
    • Trocars
    • Cutters
    • Clamps
    • Scissors
    • Elevators
    • Other Hand Instruments
  • Powered Surgical Equipment
  • Monitoring and Visualizing Systems
    • Cameras and Video Support
    • Endoscopic Trocars with Optical View
  • Endosurgical Equipment

Lung Cancer Surgical Procedures Market, by Type

  • Thoracotomy
  • Lobectomy
  • Sleeve Resection
  • Segmentectomy
  • Pneumonectomy
  • Minimally Invasive Surgeries

Lung Cancer Surgery Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Asia
  • China
  • Japan
  • India
  • RoA
  • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

The lung cancer surgery market is projected to reach USD 29.99 billion by 2021 from USD 21.58 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The high incidence and prevalence of lung cancer and rise in healthcare expenditure, increasing lung cancer awareness campaigns, and technological advancements in the lung cancer treatment are the major factors fuelling the growth of this market.

This market is segmented based on device, procedure, and region. On the basis of device, the lung cancer surgery market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. In 2016, the surgical instrument segment is expected to account for the largest share of the market due to increasing prevalence of lung cancer and growing aging population.

On the basis of procedure, the lung cancer surgery market is classified into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, sleeve resection, segmentectomy, and pneumonectomy. In 2016, the thoracotomy segment is expected to account for the largest share of the market. This large share can be attributed to increasing technological advancements in lung cancer treatment.

Lung Cancer Surgery Market

The global lung cancer surgery market is segmented into four major regions—North America, Europe, Asia, and Rest of the World. In 2016, North America is expected to account for the largest share of the market, followed by Europe. North America will continue to dominate the market in the forecast period due to availability of reimbursement for lung cancer surgeries and increasing prevalence of lung cancer in the region. However, the market in Asia is expected to witness the highest CAGR, with the growth centered on China, Japan, and India.

Major risk factors such as increasing air pollution levels and the growing number of cigarette smokers are expected to fuel the growth of the lung cancer surgical procedures market

Thoracotomy

Thoracotomy is the process of making incisions in the chest wall to gain access to the thoracic organs, such as the heart, lungs, and anterior spine. In lung cancer treatment, surgeons perform thoracotomy procedures in order to remove cancerous tissues from lungs. These surgeries are widely adopted to confirm the diagnosis of lung cancer, remove tumors and scar tissue, or fix air leaks in the lung. Lobectomy, segmentectomy, sleeve resection, and pneumonectomy are the different types of thoracotomy procedures carried out by surgeons to treat patients suffering from lung cancer

Minimally Invasive Surgeries

Minimally invasive surgeries are more advanced surgical methods than conventional open surgeries. Video-assisted thoracoscopic surgery (VATS) and robotic surgeries are examples of minimally invasive surgeries. These surgeries are especially carried out to perform lobectomy or segmentectomy procedures for treating lung cancer patients. VATS is a surgical method used for the diagnosis and treatment of lung diseases, especially non-small-cell lung carcinoma. Despite the growing acceptance for VATS resections, this minimally invasive technique has had slow adoption due to concerns regarding oncological principles, costs, possible complications, time spent on learning, and lack of trained expertise for the same. Shorter hospital stays, smaller incisions, and faster recovery are the major driving factors for minimally invasive surgeries. These advantages of minimally invasive surgeries are expected to fuel the market during the forecast period.

Key players in the lung cancer surgery market include Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

Research Methodology (Page No. - 17)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 25)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 30)
    4.1 Lung Cancer Surgical Devices Market Overview
    4.2 Geographic Analysis: Lung Cancer Surgical Devices Market, By Type
    4.3 Lung Cancer Surgical Procedures Market, By Type, 2016-2021
    4.4 Lung Cancer Surgical Devices Market, By Region, 2016-2021

5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Technological Advancements in Lung Cancer Treatment
                    5.2.1.2 Increasing Incidence and Prevalence of Lung Cancer
                    5.2.1.3 Rising Geriatric Population
                    5.2.1.4 Increasing Number of Awareness Initiatives Aimed at Early Detection of Cancer
           5.2.2 Restraints
                    5.2.2.1 High Cost of Lung Cancer Surgeries
           5.2.3 Opportunities
                    5.2.3.1 Untapped Emerging Markets
           5.2.4 Challenges
                    5.2.4.1 Entry Barriers for New Players
                    5.2.4.2 Dearth of Oncologists

6 Lung Cancer Surgical Devices Market, By Type (Page No. - 40)
    6.1 Introduction
    6.2 Surgical Instruments
           6.2.1 Hand Instruments
                    6.2.1.1 Staplers
                    6.2.1.2 Forceps
                    6.2.1.3 Retractors
                    6.2.1.4 RIB Shears
                    6.2.1.5 Trocars
                    6.2.1.6 Cutters
                    6.2.1.7 Clamps
                    6.2.1.8 Scissors
                    6.2.1.9 Elevators
                    6.2.1.10 Other Hand Instruments
    6.3 Monitoring and Visualizing Systems
           6.3.1 Cameras & Video Support
           6.3.2 Endoscopic Trocars With Optical Views
           6.3.3 Endosurgical Equipment

7 Lung Cancer Surgical Procedures Market, By Type (Page No. - 56)
    7.1 Introduction
    7.2 Thoracotomy
           7.2.1 Lobectomy
           7.2.2 Sleeve Resection
           7.2.3 Segmentectomy
           7.2.4 Pneumonectomy
    7.3 Minimally Invasive Surgeries

8 Lung Cancer Surgery Market, By Region (Page No. - 66)
    8.1 Introduction
    8.2 North America
           8.2.1 U.S.
           8.2.2 Canada
    8.3 Europe
    8.4 Asia
           8.4.1 China
           8.4.2 Japan
           8.4.3 India
           8.4.4 RoA
    8.5 Rest of the World (RoW)

9 Lung Cancer Surgical Devices Market , Competitive Landscape (Page No. - 101)
    9.1 Introduction
    9.2 Strategic Overview
    9.3 Market Share Analysis
    9.4 Competitive Situation and Trends
           9.4.1 Agreements, Partnerships, and Collaborations
           9.4.2 Product Launches
           9.4.3 Expansions
           9.4.4 Acquisitions
           9.4.5 Other Developments

10 Company Profiles (Page No. - 108)
(Overview, Products and Services, Financials, Strategy & Development)*
     10.1 Introduction
     10.2 Accuray Incorporated
     10.3 Angiodynamics Inc.
     10.4 Ethicon Us, LLC (Johnson & Johnson)
     10.5 Intuitive Surgical Inc.
     10.6 Olympus Corporation
     10.7 Teleflex Incorporated
     10.8 Ackermann Instrumente GmbH
     10.9 Karl Storz GmbH
     10.10 Scanlan International, Inc.
     10.11 Trokamed GmbH

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. - 127)
     11.1 Insights of Industry Experts
     11.2 Discussion Guide
     11.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.4 Introducing RT: Real-Time Market Intelligence
     11.5 Available Customizations
     11.6 Related Reports
     11.7 Author Details


List of Tables (85 Tables)

Table 1 Lung Cancer Surgical Devices Market Size, By Type, 2014–2021 (USD Million)
Table 2 Surgical Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 3 Surgical Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 4 Hand Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 5 Hand Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 6 Hand Instruments Market Size for Staplers, By Region, 2014–2021 (USD Million)
Table 7 Hand Instruments Market Size for Forceps, By Region, 2014–2021 (USD Million)
Table 8 Hand Instruments Market Size for Retractors, By Region, 2014–2021 (USD Million)
Table 9 Hand Instruments Market Size for RIB Shears, By Region, 2014–2021 (USD Million)
Table 10 Hand Instruments Market Size for Trocars, By Region, 2014–2021 (USD Million)
Table 11 Hand Instruments Market Size for Cutters, By Region, 2014–2021 (USD Million)
Table 12 Hand Instruments Market Size for Clamps, By Region, 2014–2021 (USD Million)
Table 13 Hand Instruments Market Size for Scissors, By Region, 2014–2021 (USD Million)
Table 14 Hand Instruments Market Size for Elevators, By Region, 2014–2021 (USD Million)
Table 15 Other Hand Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 16 Monitoring and Visualizing Systems Market Size, By Type, 2014–2021 (USD Million)
Table 17 Monitoring and Visualizing Systems Market Size, By Region, 2014–2021 (USD Million)
Table 18 Monitoring and Visualizing Systems Market Size for Cameras & Video Support, By Region, 2014–2021 (USD Million)
Table 19 Monitoring and Visualizing Systems Market Size for Endoscopic Trocars With Optical Views, By Region, 2014–2021 (USD Million)
Table 20 Endosurgical Equipment Market Size By Region, 2014–2021 (USD Million)
Table 21 Lung Cancer Surgical Procedures Market Size, By Type, 2014–2021 (USD Million)
Table 22 Market Size, By Type, 2014–2021 (No. of Procedures)
Table 23 Market Size for Thoracotomy, By Type, 2014–2021 (No. of Procedures)
Table 24 Lung Cancer Surgical Devices Market Size for Thoracotomy, By Region, 2014–2021 (USD Million)
Table 25 Lung Cancer Surgical Devices Market Size for Thoracotomy, By Region, 2014–2021 (No. of Procedures)
Table 26 Open Lobectomy vs Vats: Analysis of Costs, Surgery Time, and Length of Stay
Table 27 Lung Cancer Surgical Procedures Size for Lobectomy, By Region, 2014–2021 (No. of Procedures)
Table 28

Market Size for Sleeve Resection, By Region, 2014–2021 (No. of Procedures)
Table 29 Market Size for Segmentectomy, By Region, 2014–2021 (No. of Procedures)
Table 30 Lung Cancer Surgical Procedures Market Size for Pneumonectomy, By Region, 2014–2021 (No. of Procedures)
Table 31 Lung Cancer Surgical Procedures Market Size for Minimally Invasive Surgeries, By Region, 2014–2021 (USD Million)
Table 32 Market Size for Minimally Invasive Surgeries, By Region, 2014–2021 (No. of Procedures)
Table 33 Lung Cancer Surgical Procedures Market Size, By Region, 2014–2021 (USD Million)
Table 34 Lung Cancer Surgical Procedures Market Size, By Region, 2014–2021 (USD Million)
Table 35 Market Size, By Region, 2014–2021 (No. of Procedures)
Table 36 List of Related Conferences in North America
Table 37 North America: Lung Cancer Surgical Devices Market Size, By Country, 2014–2021 (USD Million)
Table 38 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 39 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 40 North America: Market Size, By Type, 2014–2021 (No. of Procedures)
Table 41 North America: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 42 U.S.: Lung Cancer Surgery Market Size, By Type, 2014–2021 (USD Million)
Table 43 U.S.:  Market Size, By Type, 2014–2021 (USD Million)
Table 44 U.S.: Lung Cancer Surgery Market Size, By Type, 2014–2021 (No. of Procedures)
Table 45 U.S.: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 46 Canada: Lung Cancer Surgical Procedures Market Size, By Type, 2014–2021 (USD Million)
Table 47 Canada: Lung Cancer Surgical Devices Market Size, By Type, 2014–2021 (USD Million)
Table 48 Canada: Lung Cancer Surgical Procedures Market Size, By Type, 2014–2021 (No. of Procedures)
Table 49 Canada: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 50 Europe: Market Size, By Type, 2014–2021 (USD Million)
Table 51 Europe: Lung Cancer Surgical Procedures Market Size, By Type, 2014–2021 (USD Million)
Table 52 Europe: Market Size, By Type, 2014–2021 (No. of Procedures)
Table 53 Europe: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 54 Asia: Lung Cancer Surgical Procedures Market Size, By Country, 2014–2021 (USD Million)
Table 55 Asia: Lung Cancer Surgical Devices Market Size, By Country, 2014–2021 (No. of Procedures)
Table 56 Asia: Market Size, By Type, 2014–2021 (USD Million)
Table 57 Asia: Lung Cancer Surgery Market Size, By Type, 2014–2021 (USD Million)
Table 58 Asia: Lung Cancer Surgical Procedures Market Size, By Type, 2014–2021 (No. of Procedures)
Table 59 Asia: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 60 China: Lung Cancer Surgical Devices Market Size, By Type, 2014–2021 (USD Million)
Table 61 China: Market Size, By Type, 2014–2021 (USD Million)
Table 62 China: Market Size, By Type, 2014–2021 (No. of Procedures)
Table 63 China: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 64 Japan: Lung Cancer Surgery Market Size, By Type, 2014–2021 (USD Million)
Table 65 Japan: Lung Cancer Surgical Devices Market Size, By Type, 2014–2021 (USD Million)
Table 66 Japan: Market Size, By Type, 2014–2021 (No. of Procedures)
Table 67 Japan: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 68 India: Lung Cancer Surgical Devices Market Size, By Type, 2014–2021 (USD Million)
Table 69 India: Market Size, By Type, 2014–2021 (USD Million)
Table 70 India:Market Size, By Type, 2014–2021 (No. of Procedures)
Table 71 India: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 72 RoA: Lung Cancer Surgical Procedures Market Size, By Type, 2014–2021 (USD Million)
Table 73 RoA: Lung Cancer Surgery Market Size, By Type, 2014–2021 (USD Million)
Table 74 RoA: Market Size, By Type, 2014–2021 (No. of Procedures)
Table 75 RoA: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 76 RoW: Lung Cancer Surgical Devices Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoW: Lung Cancer Surgery Market Size, By Type, 2014–2021 (USD Million)
Table 78 RoW: Lung Cancer Surgery Market Size, By Type, 2014–2021 (No. of Procedures)
Table 79 RoW: Thoracotomy Market Size, By Type, 2014–2021 (No. of Procedures)
Table 80 Growth Strategy Matrix, 2014–2016
Table 81 Agreements, Partnerships, and Collaborations, 2014–2016
Table 82 Product Launches, 2014–2016
Table 83 Expansions, 2014–2016
Table 84 Acquisitions, 2014–2016
Table 85 Other Developments, 2014–2016


List of Figures (44 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Lung Cancer Surgery Market: Bottom-Up Approach
Figure 4 Lung Cancer Surgery Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Lung Cancer Surgery Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 7 Global Lung Cancer Surgical Procedures Market Size, By Type, 2016 vs 2021 (No. of Procedures)
Figure 8 Global Lung Cancer Surgical Devices Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Lung Cancer Surgical Devices Market Size, By Region
Figure 10 Global Lung Cancer Surgical Devices Market to Witness Moderate Growth During the Forecast Period
Figure 11 Surgical Instruments Segment to Dominate the Global Lung Cancer Surgical Devices Market in 2016
Figure 12 Thoracotomy Segment to Dominate the Global Lung Cancer Surgery Market in 2016
Figure 13 Asian Market to Witness the Highest Growth During the Forecast Period
Figure 14 Lung Cancer Surgical Procedures Market : Drivers, Restraints, Opportunities, and Challenges
Figure 15 Market Segmentation, By Type
Figure 16 Surgical Instruments Will Continue to Dominate the Lung Cancer Surgical Devices Market During the Forecast Period
Figure 17 The Thoracotomy Segment Will Continue to Dominate the Lung Cancer Surgical Procedures Market During the Forecast Period
Figure 18 The Lobectomy Segment Will Continue to Dominate the Lung Cancer Surgical Procedures Market for Thoracotomy During the Forecast Period
Figure 19 Lung Cancer Surgical Procedures Market , By Region (Market Size and Growth Rate), 2016–2021
Figure 20 Market, By Region (No. of Procedures and Growth Rate), 2016 vs 2021
Figure 21 North America: Lung Cancer Surgery Market Snapshot
Figure 22 U.S. to Dominate the North American Lung Cancer Surgical Devices Market in 2016
Figure 23 Surgical Instruments, the Largest Segment in the North American Lung Cancer Surgical Devices Market in 2016
Figure 24 Surgical Instruments, the Largest Segment in the U.S. Lung Cancer Surgical Devices Market in 2016
Figure 25 Surgical Instruments, the Largest Segment in the Canadian Lung Cancer Surgical Devices Market in 2016
Figure 26 Surgical Instruments, the Largest Segment in the European Lung Cancer Surgical Devices Market in 2016
Figure 27 Asia: Lung Cancer Surgery Market Snapshot
Figure 28 China Estimated to Dominate the Asian Market in 2016
Figure 29 Surgical Instruments, the Largest Segment in the Asian Lung Cancer Surgical Devices Market in 2016
Figure 30 Lobectomy Surgeries Account for the Largest Share in the Asian Thoracotomy Market in 2016
Figure 31 Surgical Instruments to Hold A Major Share of the Chinese Lung Cancer Surgery Market in 2016
Figure 32 Surgical Instruments to Hold A Major Share of the Japanese Market in 2016
Figure 33 Surgical Instruments to Dominate the Indian Lung Cancer Surgical Devices Market in 2016
Figure 34 Surgical Instruments to Hold A Major Share of the RoA Market in 2016
Figure 35 Surgical Instruments to Hold A Major Share of the RoW Lung Cancer Surgery Market in 2016
Figure 36 Key Developments Witnessed in the Lung Cancer Surgery Market, 2014–2016
Figure 37 Lung Cancer Surgery Market Share Analysis, By Key Player, 2015
Figure 38 Geographic Revenue Mix of the Top Six Market Players
Figure 39 Accuray Incorporated: Company Snapshot (2015)
Figure 40 Angiodynamics Inc.: Company Snapshot (2015)
Figure 41 Johnson & Johnson: Company Snapshot (2015)
Figure 42 Intuitive Surgical Inc.: Company Snapshot (2015)
Figure 43 Olympus Corporation: Company Snapshot (2015)
Figure 44 Teleflex Incorporated: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 4960
Published ON
Jan, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Lung Cancer Surgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved